Steven M. Paul - Insider Trading & Ownership

Entity: Individual
Location: C/O Eli Litty & Co, LIIy Corporate Center Dc 1093, Indianapolis, IN
Summary: The estimated net worth of Steven M. Paul is at least $4.95M dollars as of June 6, 2024. Steven M. Paul is the Director of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $4.77M. Steven M. Paul is the Director of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $185K.
All Insider Reports: All Insider Reports

Ownership of Steven M. Paul

Symbol	Company	Relationship	Holdings Value	Report Period
RAPP	Rapport Therapeutics, Inc.	Director	$4.77M	Jun 6, 2024
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Director	$185K	Apr 1, 2022
KRTX	Karuna Therapeutics, Inc.	Director	$0	Mar 18, 2024
SAGE	Sage Therapeutics, Inc.	Director		Jan 3, 2024
VYGR	Voyager Therapeutics, Inc.	Director		Jun 3, 2021

Showing 1 to 5 of 5 entries

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
Loading...

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.